HOME >> MEDICINE >> NEWS
BMJ highlights lack of international cooperation to investigate scientific fraud

This week, the BMJ expresses concern about the validity of a paper it published in 1992 written by Dr Ram B Singh of Moradabad, India.

We also highlight the case of another author, R K Chandra, who had a study retracted by the journal Nutrition earlier this year. As with Singh, serious doubts now hang over the rest of his work.

The stories of Singh and Chandra have been told to highlight the problems associated with investigating allegations of research fraud and to challenge the international scientific community to take action where necessary.

In 1992, the BMJ published a paper by Dr Singh on the protective effects of diet on the heart. But doubts were soon raised about this study and subsequent manuscripts submitted by the same author.

In the absence of answers from the author, Richard Smith, then editor of the BMJ, tried to find an authority in India that would investigate and resolve the doubts over Singh's work, but no institution would take on the task. A statistical analysis of one of Singh's papers, also published in this week's issue, concludes that data "were either fabricated or falsified."

After several years of fruitless correspondence, the BMJ decided it had no option but to publish an account of the suspicions and the failed attempts to have them resolved.

Richard Smith, who left the BMJ in 2004, accepts that it has taken far too long to bring the case of Dr Singh to light, and admits that "the failure is in part mine." However, he adds that "the bigger shame lies with the scientific community that lacks means to investigate these international scandals and has to leave it to an individual journal."

He resolutely stands by the decision to publish the saga, and believes that the scientific community has an obligation to the public to do better.

But once the validity of one study is called into question, who should investigate the rest of the author's work and, if necessary, mete out pun
'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
28-Jul-2005


Page: 1 2

Related medicine news :

1. Research highlights from Thoracic Society Conference
2. SCAI highlights study using wireless technology to speed care of heart attack patients
3. SCAI Founders Lecture highlights remarkable progress in catheter-based aortic valve replacement
4. Other highlights in the May 2 JNCI
5. Latest IPCC report highlights need for integrated climate/human behavior models
6. New report highlights aromatase inhibitor side effects
7. Study highlights new and cheaper way to treat heroin addiction
8. Other highlights in the Dec. 6 JNCI
9. Conference session highlights importance of interdisciplinary approach to Earth system science
10. $36.4 billion a year: Cost of HIV/AIDS highlights racial and ethnic disparities
11. Literature review highlights options for self-management of asthma exacerbations

Post Your Comments:
(Date:5/22/2013)... and Los Angeles, CA (PRWEB) May 22, 2013 ... the board, The J. M. Smucker Company, and ... Achievement Awards yesterday at the GS1 General Assembly and ... California. Mr. Smucker and Mr. Wegman were recognized for ... GS1 Standards - the most broadly used supply chain ...
(Date:5/22/2013)... May 22 (HealthDay News) -- Children and teens exposed ... likely to develop cancer, according to a large, long-term ... a group of 10,000 young people who each had ... be expected to occur within 10 years, according to ... doctors should carefully weight the risks to patients when ...
(Date:5/22/2013)... available in German . ... Foundation) is establishing 11 new Research Training Groups to ... was made by the relevant Grants Committee in Bonn. ... to the new programmes for an initial period of ... 11 new Research Training Groups, the Grants Committee approved ...
(Date:5/22/2013)... run, encouraging a baby to finish the last ounce in ... Though the calories soon burn off, a bad habit remains. ... Forste found that clinical obesity at 24 months of age ... overweight at age two, it puts you on a trajectory ... and adolescence and as an adult," said Forste. "That,s a ...
(Date:5/22/2013)... May 22, 2013 The new 13-valent pneumococcal ... the previous version used prior to 2010, the 7-valent ... study published today in Vaccine . , The ... beginning in 2010 after a series of trials. These ... range of pneumococcal types than the previously used PCV7, ...
Breaking Medicine News(10 mins):Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2Health News:DFG establishes 11 new research training groups 2Health News:DFG establishes 11 new research training groups 3Health News:DFG establishes 11 new research training groups 4Health News:DFG establishes 11 new research training groups 5Health News:Overeating learned in infancy, study suggests 2Health News:Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine 2
(Date:5/22/2013)... -- Cellular Biomedicine Group (OTCQB: CBMG) today announced that it ... enrollment required for its Phase I trial to evaluate the ... Dendritic Cell) therapy for hepatocellular carcinoma (HCC), the most common ... no Severe Adverse Effect (SAE) reported. The Phase ... NIH under number NCT01828762 (click here to view) ...
(Date:5/22/2013)... May 22, 2013 PRNewswire – iBio, ... of a vaccine candidate for the newly emerged ... laboratory using the iBioLaunch™ platform. This validation milestone ... initial antigen sequence information to purification of recombinant ... ) The iBioLaunch platform eliminates the ...
(Date:5/22/2013)... TEL AVIV, Israel , May 22, 2013 /PRNewswire/ ... "Company") (TASE, NASDAQ: EMITF) announced today, further to the ... filed a motion with the Tel Aviv ... of its unsecured creditors and shareholders for the approval ... debt pursuant to a plan of arrangement (the "Arrangement") ...
Breaking Medicine Technology:Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 2Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 3iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 3
Cached News: